554 related articles for article (PubMed ID: 17078510)
1. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in vaccine adjuvants.
Singh M; O'Hagan DT
Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
4. Advances in vaccine adjuvants for infectious diseases.
Singh M; Srivastava I
Curr HIV Res; 2003 Jul; 1(3):309-20. PubMed ID: 15046255
[TBL] [Abstract][Full Text] [Related]
5. Advances in vaccine adjuvants.
Singh M; O'Hagan D
Nat Biotechnol; 1999 Nov; 17(11):1075-81. PubMed ID: 10545912
[TBL] [Abstract][Full Text] [Related]
6. Microparticle-based technologies for vaccines.
O'Hagan DT; Singh M; Ulmer JB
Methods; 2006 Sep; 40(1):10-9. PubMed ID: 16997709
[TBL] [Abstract][Full Text] [Related]
7. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in immunological adjuvants: the development of particulate antigen delivery systems.
O'Hagan DT
Expert Opin Investig Drugs; 1998 Mar; 7(3):349-59. PubMed ID: 15991977
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in vaccine delivery systems.
O'Hagan DT
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
[TBL] [Abstract][Full Text] [Related]
10. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
11. The path to a successful vaccine adjuvant--'the long and winding road'.
O'Hagan DT; De Gregorio E
Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
[TBL] [Abstract][Full Text] [Related]
12. A need for effective adjuvants.
Bunce CJ; Morse MA
Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
[No Abstract] [Full Text] [Related]
13. Particulate delivery systems for animal vaccines.
Scheerlinck JP; Greenwood DL
Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
[TBL] [Abstract][Full Text] [Related]
14. Microparticles as vaccine adjuvants and delivery systems.
O'Hagan DT; Singh M
Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
[TBL] [Abstract][Full Text] [Related]
15. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.
Baldridge JR; Crane RT
Methods; 1999 Sep; 19(1):103-7. PubMed ID: 10525445
[TBL] [Abstract][Full Text] [Related]
16. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
17. Bacterial ghosts as adjuvant particles.
Riedmann EM; Kyd JM; Cripps AW; Lubitz W
Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
[TBL] [Abstract][Full Text] [Related]
18. ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.
Drane D; Gittleson C; Boyle J; Maraskovsky E
Expert Rev Vaccines; 2007 Oct; 6(5):761-72. PubMed ID: 17931156
[TBL] [Abstract][Full Text] [Related]
19. GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.
Garçon N; Chomez P; Van Mechelen M
Expert Rev Vaccines; 2007 Oct; 6(5):723-39. PubMed ID: 17931153
[TBL] [Abstract][Full Text] [Related]
20. Adjuvants and delivery systems for viral vaccines--mechanisms and potential.
Jennings R; Simms JR; Heath AW
Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
